ORIC
ORIC
US68622P1093
Oric Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
143.004.000 142.895.000
0.1%
Operating Income -143.004.000 -142.895.000
0.1%
Pretax Income -129.468.000 -127.847.000
1.3%
Net Income Common Stockholders -129.468.000 -127.847.000
1.3%
-- --
--
-- --
--
ende